Loading company…
MicrobiotiX develops microbiota transplant products and bacteriophage research for antibiotic-resistant infections.
Founded in 2016 and based in Seoul, MicrobiotiX develops oral fecal microbiota transplant capsules and researches bacteriophages. Its work includes potential treatments for antibiotic-resistant bacteria using intestinal microbes and bacteriophages. The company plans to study FMT applications in cancer treatment and metabolic diseases.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in